These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 20880991

  • 21. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A, Hennessey K, Pitigoi D, Ion-Nedelcu N, Lupulescu E, Walls L, Bellini W, Strebel P.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 15; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 23. Measles, mumps and rubella: control by vaccination.
    van Druten JA, de Boo T, Plantinga AD.
    Dev Biol Stand; 1986 Dec 15; 65():53-63. PubMed ID: 3556777
    [Abstract] [Full Text] [Related]

  • 24. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.
    N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278
    [Abstract] [Full Text] [Related]

  • 25. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
    Domínguez A, Torner N, Martínez A, Costa J, Plans P, Ciruela P, Salleras L.
    Vaccine; 2006 Feb 27; 24(9):1433-7. PubMed ID: 16226357
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS).
    Poethko-Müller C, Mankertz A.
    Vaccine; 2011 Oct 19; 29(45):7949-59. PubMed ID: 21872633
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Nov 09; 50(44):976-9. PubMed ID: 11724151
    [Abstract] [Full Text] [Related]

  • 31. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S, Kakarriqi E, Xibinaku M, Ion-Nedelcu N, Bukli M, Emiroglu N, Uzicanin A.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013.
    Simone B, Balasegaram S, Gobin M, Anderson C, Charlett A, Coole L, Maguire H, Nichols T, Rawlings C, Ramsay M, Oliver I.
    Vaccine; 2014 Aug 06; 32(36):4681-8. PubMed ID: 24996125
    [Abstract] [Full Text] [Related]

  • 34. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM.
    Saudi Med J; 2006 Jan 06; 27(1):63-9. PubMed ID: 16432596
    [Abstract] [Full Text] [Related]

  • 35. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I, Kontio M, Paunio M, Peltola H.
    Expert Rev Vaccines; 2010 Sep 06; 9(9):1045-53. PubMed ID: 20822347
    [Abstract] [Full Text] [Related]

  • 36. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination.
    Song N, Gao Z, Wood JG, Hueston L, Gilbert GL, MacIntyre CR, Quinn HE, Menzies R, McIntyre P.
    Vaccine; 2012 Jun 08; 30(27):4073-8. PubMed ID: 22554644
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J.
    Int J Infect Dis; 2008 Jan 08; 12(1):43-6. PubMed ID: 17950020
    [Abstract] [Full Text] [Related]

  • 38. Eliminating congenital rubella: a seroepidemiological study on women of childbearing age and MMR vaccine coverage in newborns.
    Lo Giudice D, Cannavò G, Capua A, Grillo OC, La Fauci V, Puliafito A, Sindoni D, Squeri R, Calimeri S.
    J Prev Med Hyg; 2009 Dec 08; 50(4):236-40. PubMed ID: 20812520
    [Abstract] [Full Text] [Related]

  • 39. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb 08; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 40. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
    Santos JI, Nakamura MA, Godoy MV, Kuri P, Lucas CA, Conyer RT.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S243-50. PubMed ID: 15106118
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.